Product registration


When a product is determined safe and effective from the phase 3 trials, it must be author ised in each individual country before the product can be marketed. All data generated during the development period is collected and submitted as the documentation to the authorities in the US (FDA), the EU (EMEA), Japan (PMDA) and other countries requiring their own national approvals.

Time: 1–1.5 years.